Imugene is passionate about bringing effective new treatments and options to patients who need them.

Participation in Imugene clinical trials is always based on the patient’s own decision.

For further information on how to participate in our clinical trials, please contact your treating physician.

SHAREHOLDER Enquiries SHAREHOLDEREnquiries@imugene.com

Media Enquiries matt@nwrcommunications.com.au

Share Registry hello@automic.com.au

Automic Group

1.300.288.664 (Australia)

+61.2.9698.5414 (International)

Imugene Limited

ABN 99 009 179 551

Suite 12.01, Level 12

4-6 Bligh Street

SYDNEY, NSW 2000

AUSTRALIA